Thermo Fisher Scientific has once again demonstrated its excellence in contract manufacturing, as recognized by its pharma and biopharma customers for the 11th consecutive year. 

The CDMO Leadership Awards, sponsored by Outsourced Pharma and Life Science Connect, have honored Thermo Fisher with five awards across various categories including capabilities, compatibility, expertise, and quality and reliability. These accolades were bestowed upon Thermo Fisher by three distinct customer groups: big pharma, small pharma, and both, reaffirming the company's widespread recognition and trust within the industry.

The awards, based on evaluations from customers who worked with contract manufacturers over the past 18 months, involved a rigorous assessment of 98 companies across 23 performance metrics. Thermo Fisher's consistent success in these awards highlights its dedication to exceeding customer expectations and providing exceptional service to the global pharma and biotech community.

Jennifer Cannon, President of Commercial Operations for Thermo Fisher's pharma services business, expressed gratitude for the recognition, stating, "We're honored by this demonstration of our customers' trust and confidence in Thermo Fisher and very thankful for their recognition of our focus on exceeding expectations. We're committed to being the partner our customers rely on to help them deliver for patients around the world."

Louis Garguilo, Chief Editor and Conference Chair of Outsourced Pharma, commended the resilience and adaptability of CDMOs amidst challenging circumstances, stating, "Through it all, CDMOs stayed focused, and also adapted to customer and market needs. Those best at serving their customers (and thus patients) are recognized as the 2024 CDMO Leadership Award winners."